Atlas Trials

Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy

Clinical trial NCT01732146 · COMPLETED

Trial details

NCT number
NCT01732146
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypoxic Ischemic Encephalopathy
Start date
2013-03-28
Primary completion
2017-02-14
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.